WEST HAVEN, Conn.--(BUSINESS WIRE)--Eugene Seymour, MD, MPH, Chief Executive Officer of NanoViricides, Inc. (Pink Sheets: NNVC) announced today that the preliminary animal studies of RabiCide™ efficacy are now underway. RabiCide was developed by the company at the behest of Vietnamese health officials. This study is being conducted by the scientists of the National Institute of Hygiene and Epidemiology in Vietnam (NIHE), with the assistance of the Nanoviricides team who supplied the drug.
